1. Separating the wheat from the chaff

   • Claus Runge

   Editorial 23 February 2012 Pages: 121 - 126

   

2. Towards a social discount rate for the economic evaluation of health technologies in Germany: an exploratory analysis

   • Mareike Schad
   • Jürgen John

   Original Paper 19 December 2010 Pages: 127 - 144

   

3. Cost-effectiveness of treatment with etanercept for psoriasis in Sweden

   • Christopher Knight
   • Josephine Mauskopf
   • Robert Boggs

   Original Paper 06 March 2011 Pages: 145 - 156

   

4. Malpractice liability, technology choice and negative defensive medicine

   • Eberhard Feess

   Original Paper 11 January 2011 Pages: 157 - 167

5. Decision-making in general practice: the effect of financial incentives on the use of laboratory analyses

   • Siri Fauli Munkerud

   Original Paper 07 January 2011 Pages: 169 - 180

   

6. Treating pneumonia in critical care in the United Kingdom following failure of initial antibiotic: a cost-utility analysis comparing meropenem with piperacillin/tazobactam

   • Steven J. Edwards
   • Sarah Wordsworth
   • Mike J. Clarke

   Original Paper 18 January 2011 Pages: 181 - 192

   

7. Exploring the disparities of regional health care expenditures in Switzerland: some empirical evidence

   • Oliver Reich
   • Cornelia Weins
   • Magdalena Thöni

   Original Paper 03 February 2011 Pages: 193 - 202

   

8. Defining care products to finance health care in the Netherlands

   • Machiel Westerdijk
   • Joost Zuurbier
   • Sarah Prins

   Original Paper Open access 25 February 2011 Pages: 203 - 221